共 206 条
[1]
Chen N(2020)Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study Lancet 395 5017-5513
[2]
Zhou M(2020)COVID-19 illness in native and immunosuppressed states: a clinical-therapeutic staging proposal J Heart Lung Transplant 117 11727-11734
[3]
Dong X(2020)Dysregulation of immune response in patients with COVID-19 in Wuhan, China Clin Infect Dis 142 1176-1189
[4]
Siddiqu HK(2020)Cell entry mechanisms of SARS-CoV-2 PNAS 2020 7527953-550
[5]
Mehra MR(2020)Immunothrombotic dysregulation in COVID-19 pneumonia is associated with respiratory failure and coagulopathy Circulation 30 544-986
[6]
Qin C(2020)Neutrophil extracellular traps (NETs) and damage-associated molecular patterns (DAMPs): two potential targets for COVID-19 treatment Mediat Inflamm 43 985-540
[7]
Zhou L(2020)Pharmaceutical immunoglobulins reduce neutrophil extracellular trap formation and ameliorate the development of MPO-ANCA-associated vasculitis Mod Rheumatol 81 537-e2518
[8]
Hu Z(2020)SARS-CoV-2 downregulation of ACE2 and pleiotropic effects of ACEIs/ARBs Hypertens Res 2 e0280-203
[9]
Shang J(2020)Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics Drug Dev Res. 63 e02483-1182
[10]
Wan Y(2020)Intravenous immunoglobulin plus methylprednisolone mitigate respiratory morbidity in coronavirus disease 2019 Crit Care Explor 173 195-2044